BY 686
Latest Information Update: 09 Feb 2001
At a glance
- Originator ALTANA Pharma
- Class Antiulcers
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 09 Feb 2001 Profile reviewed but no significant changes made
- 16 Apr 1997 No-Development-Reported for Peptic ulcer in Germany (Unknown route)